InterventionsHuman trial

Post Hoc Analysis of Efficacy and Safety Outcomes of Efsitora vs. Once-Daily Insulin in Type 2 Diabetes by GLP-1RA Use across QWINT-1–4 Trials

ADA Scientific Sessions 2026 Abstract

The paper

Alice Y. Cheng, Melanie Davies, Tadej Battelino,
Show 3 more authorsConan Tu, Kristen Syring, Shyam Cp,
Michael B. Davidson

Mississauga

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 1746-P

doi.org/10.2337/db26-1746-p